Home

Michael A. Metzger, CEO: Syndax Pharmaceuticals SNDX Sell · Filed 25/09/08

Trade details

Type
Insider sale
Amount
$2,581,407.87
Shares · price
157,307 sh · $16.41 a share
Held after
298,661 sh
Trade date
25/09/08
Filed
25/09/08
Days to filing
0 days

Sold 34.5% of holdings

Share of holding sold
34.5%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/09~25/10/08

Michael A. Metzger's recent trades

  • Michael A. Metzger

    Planned sale10b5-1 planSyndax Pharmaceuticals

    $752.4K

    Filed 07/08

  • Michael A. Metzger

    SellSyndax Pharmaceuticals

    $130K

    Filed 06/02

  • Michael A. Metzger

    Planned saleSyndax Pharmaceuticals

    $130K

    Filed 06/01

  • Michael A. Metzger

    SellSyndax Pharmaceuticals

    $360.9K

    Filed 02/10

  • Michael A. Metzger

    Planned saleSyndax Pharmaceuticals

    $360.8K

    Filed 02/09

Michael A. Metzger, CEO — sold $2.6M of Syndax Pharmaceuticals SNDX · 34.5% of holdings · 10b5-1 plan | Whalegun